Headspace solid-phase microextraction/gas chromatography-mass spectrometry (HS-SPME/GC-MS) analysis combined with 'relative odour activity value (ROAV)' was used to monitor changes in key volatile compounds in peanut oil, soybean oil, rapeseed oil, and linseed oil during ambient storage. Volatile composition and oxidation process were compared among edible oil samples. The differences in the volatile contents of edible oils led to their characteristic flavour. Aldehydes featured a relatively high content and low odour threshold and mainly contributed to the flavour of edible oils. The key flavour compounds included pentanal, hexanal, octanal, nonanal, trans-2-heptenal, and benzaldehyde, which are important oxidative degradation products of oleic acid and linoleic acid. The formation of key volatile oxidation compounds was affected by different oxidation processes during ambient storage. Certain aldehydes increased with oxidation level, whereas other aldehydes initially increased then decreased. Correlation analysis showed that the concentrations of several volatile compounds progressively increased during oxidation. The key volatile oxidation compounds formed during oil storage at ambient temperature are partly different from those generated at high temperatures. Volatile oxidation compounds can be a marker for monitoring the oxidation degree of edible oils during ambient storage.

Tumor-associated macrophages (TAMs) are abundant, nearly accounting for 30–50% of stromal cells in the tumor microenvironment. TAMs exhibit an immunosuppressive M2-like phenotype in advanced cancer, which plays a crucial role in tumor growth, invasion and migration, angiogenesis and immunosuppression. Consequently, the TAM-targeting therapies are particularly of significance in anti-cancer strategies. The application of TAMs as anti-cancer targets is expected to break through traditional tumor-associated therapies and achieves favorable clinical effect. However, the heterogeneity of TAMs makes the strategy of targeting TAMs variable and uncertain. Discovering the subset specificity of TAMs might be a future option for targeting TAMs therapy. Herein, the review focuses on highlighting the different modalities to modulate TAM’s functions, including promoting the phagocytosis of TAMs, TAMs depletion, blocking TAMs recruitment, TAMs reprogramming and suppressing immunosuppressive tumor microenvironment. We also discuss about several ways to improve the efficacy of TAM-targeting therapy from the perspective of combination therapy and specificity of TAMs subgroups.

Obese but not overweight patients appear to have worse OS than normal-weight patients with CRC. The associations of obesity and overweight with OS in CRC patients majorly depend upon the timing of BMI assessment.

No abstract